Comparison of 0.1% and 0.3% Nepafenac eye drops on reduction of  macular thickness and improvement of visual acuity in patients with  diabetic macular edema

Dr. Rakesh Verma, Dr Rachana Gahlawat

Comparison of 0.1% and 0.3% Nepafenac eye drops on reduction of macular thickness and improvement of visual acuity in patients with diabetic macular edema

Authors

Dr. Rakesh Verma, Dr Rachana Gahlawat

Keywords:

Macular edema, Non-steroidal anti-inflammatory agents, Ophthalmology

Abstract

Background: Macular thickening is a postoperative complication following cataractsurgery, even with uncomplicated small-incision phacoemulsification surgery.Subclinical cystoid macular edema

References

Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA 2003;290:2057-60.

Bardoloi N, Sarkar S, Pilania A, Das H. Efficacy and safety of dropless cataract surgery. Indian J Ophthalmol 2020;68:1081-5.

Downloads

Published

2025-10-10

How to Cite

Dr. Rakesh Verma, Dr Rachana Gahlawat. (2025). Comparison of 0.1% and 0.3% Nepafenac eye drops on reduction of macular thickness and improvement of visual acuity in patients with diabetic macular edema . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2447–2455. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1071